175 related articles for article (PubMed ID: 34670582)
1. Cost impact of procalcitonin-guided decision making on duration of antibiotic therapy for suspected early-onset sepsis in neonates.
Geraerds AJLM; van Herk W; Stocker M; El Helou S; Dutta S; Fontana MS; Schuerman FABA; van den Tooren-de Groot RK; Wieringa J; Janota J; van der Meer-Kappelle LH; Moonen R; Sie SD; de Vries E; Donker AE; Zimmerman U; Schlapbach LJ; de Mol AC; Hoffman-Haringsma A; Roy M; Tomaske M; Kornelisse RF; van Gijsel J; Visser EG; van Rossum AMC; Polinder S
Crit Care; 2021 Oct; 25(1):367. PubMed ID: 34670582
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns).
Stocker M; van Herk W; El Helou S; Dutta S; Fontana MS; Schuerman FABA; van den Tooren-de Groot RK; Wieringa JW; Janota J; van der Meer-Kappelle LH; Moonen R; Sie SD; de Vries E; Donker AE; Zimmerman U; Schlapbach LJ; de Mol AC; Hoffman-Haringsma A; Roy M; Tomaske M; Kornelisse RF; van Gijsel J; Visser EG; Willemsen SP; van Rossum AMC;
Lancet; 2017 Aug; 390(10097):871-881. PubMed ID: 28711318
[TBL] [Abstract][Full Text] [Related]
3. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial.
Stocker M; Fontana M; El Helou S; Wegscheider K; Berger TM
Neonatology; 2010; 97(2):165-74. PubMed ID: 19776651
[TBL] [Abstract][Full Text] [Related]
4. Reduction of Duration of Antibiotic Therapy for Suspected Early-Onset Sepsis in Late-Preterm and Term Newborns After Implementation of a Procalcitonin-Guided Algorithm: A Population-Based Study in Central Switzerland.
Zihlmann-Ji J; Braun C; Buettcher M; Hodel M; Lehnick D; Stocker M
Front Pediatr; 2021; 9():702133. PubMed ID: 34368029
[No Abstract] [Full Text] [Related]
5. Neonatal Procalcitonin Intervention Study (NeoPInS): Effect of Procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal early-onset sepsis: A multi-centre randomized superiority and non-inferiority Intervention Study.
Stocker M; Hop WC; van Rossum AM
BMC Pediatr; 2010 Dec; 10():89. PubMed ID: 21143869
[TBL] [Abstract][Full Text] [Related]
6. Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis.
Collins CD; Brockhaus K; Sim T; Suneja A; Malani AN
Am J Health Syst Pharm; 2019 Aug; 76(16):1219-1225. PubMed ID: 31369118
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands.
Kip MMA; van Oers JA; Shajiei A; Beishuizen A; Berghuis AMS; Girbes AR; de Jong E; de Lange DW; Nijsten MWN; IJzerman MJ; Koffijberg H; Kusters R
Crit Care; 2018 Nov; 22(1):293. PubMed ID: 30424796
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness Analysis of a Procalcitonin-Guided Decision Algorithm for Antibiotic Stewardship Using Real-World U.S. Hospital Data.
Voermans AM; Mewes JC; Broyles MR; Steuten LMG
OMICS; 2019 Oct; 23(10):508-515. PubMed ID: 31509068
[TBL] [Abstract][Full Text] [Related]
10. Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial.
Jeon K; Suh JK; Jang EJ; Cho S; Ryu HG; Na S; Hong SB; Lee HJ; Kim JY; Lee SM
J Korean Med Sci; 2019 Apr; 34(14):e110. PubMed ID: 30977312
[TBL] [Abstract][Full Text] [Related]
11. The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis.
Mewes JC; Pulia MS; Mansour MK; Broyles MR; Nguyen HB; Steuten LM
PLoS One; 2019; 14(4):e0214222. PubMed ID: 31013271
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
Kyriazopoulou E; Liaskou-Antoniou L; Adamis G; Panagaki A; Melachroinopoulos N; Drakou E; Marousis K; Chrysos G; Spyrou A; Alexiou N; Symbardi S; Alexiou Z; Lagou S; Kolonia V; Gkavogianni T; Kyprianou M; Anagnostopoulos I; Poulakou G; Lada M; Makina A; Roulia E; Koupetori M; Apostolopoulos V; Petrou D; Nitsotolis T; Antoniadou A; Giamarellos-Bourboulis EJ
Am J Respir Crit Care Med; 2021 Jan; 203(2):202-210. PubMed ID: 32757963
[No Abstract] [Full Text] [Related]
13. Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis?
Harrison M; Collins CD
Infect Control Hosp Epidemiol; 2015 Mar; 36(3):265-72. PubMed ID: 25695167
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of procalcitonin in neonatal early-onset sepsis].
Wang SY; Yu JL
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Apr; 22(4):316-322. PubMed ID: 32312368
[TBL] [Abstract][Full Text] [Related]
15. PROCalcitonin-based algorithm for antibiotic use in Acute Pancreatitis (PROCAP): study protocol for a randomised controlled trial.
Siriwardena AK; Jegatheeswaran S; Mason JM; Baltatzis M; Chan A; Sheen AJ; O'Reilly D; Jamdar S; Deshpande R; de Liguori Carino N; Satyadas T; Qamruddin A; Hayden K; Parker MJ; Butler J; Rajai A; McIntyre B
Trials; 2019 Jul; 20(1):463. PubMed ID: 31358032
[TBL] [Abstract][Full Text] [Related]
16. Association of inflammatory biomarkers with subsequent clinical course in suspected late onset sepsis in preterm neonates.
Kurul Ş; Simons SHP; Ramakers CRB; De Rijke YB; Kornelisse RF; Reiss IKM; Taal HR
Crit Care; 2021 Jan; 25(1):12. PubMed ID: 33407770
[TBL] [Abstract][Full Text] [Related]
17. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.
Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y
Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin-Guided Antibiotic Discontinuation Might Shorten the Duration of Antibiotic Treatment Without Increasing Pneumonia Recurrence.
Akagi T; Nagata N; Wakamatsu K; Harada T; Miyazaki H; Takeda S; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Wada K; Ueda Y; Fujita M; Watanabe K
Am J Med Sci; 2019 Jul; 358(1):33-44. PubMed ID: 31084909
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross-over, interventional study.
Chomba RN; Moeng MS; Lowman W
S Afr J Surg; 2020 Sep; 5(3):143-149. PubMed ID: 33231007
[TBL] [Abstract][Full Text] [Related]
20. A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis.
Kip MM; Kusters R; IJzerman MJ; Steuten LM
J Med Econ; 2015; 18(11):944-53. PubMed ID: 26105574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
